Drug
cyclo(Trp-Asp-Pro-Val-Leu) clinical trials
Also written BQ-123.
- studies test it
- 15
- open now
- 1
- in phase 3
- 0
- first study started
- 1998
Keep track of what changes. Save the cyclo(Trp-Asp-Pro-Val-Leu) studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- BQ-123
- 12
Combined with it in one product
Studies by the year they started
15 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 4
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 15
Medical University of Vienna (4) · University of Edinburgh (3) · Brigham and Women's Hospital (2) · The University of Texas at Arlington (1) · VA Office of Research and Development (1) · Mayo Clinic (1) · D. Walter Wray (1) · University of Southern Denmark (1)
Often tested with
Tested in the same studies.
BQ 788 (4) · Arginine (1) · Endothelin 1 (1) · Sapropterin (1) · Omega-N-Methylarginine (1) · Ascorbic Acid (1) · Vitamin E (1) · Thioctic Acid (1)
Studies
Open first, then newest update. How each study uses cyclo(Trp-Asp-Pro-Val-Leu) is read from its arms, and is right about nine times in ten.
Testing it · 15
- : Vascular Function in Health and DiseaseRecruitingPhase 1D. Walter WrayNCT02966665Written as BQ-123
- The Effect of Endothelin and L-Arginine on Racial Differences in VasoconstrictionCompletedPhase 1The University of Texas at ArlingtonNCT03679780Written as BQ-123
- The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of EndothelinCompletedNot applicableUniversity of EdinburghNCT00745693Written as BQ-123 and BQ-788
- Endothelin Antagonism in ANCA VasculitisCompletedNot applicableUniversity of EdinburghNCT02062346Written as BQ123
- Contribution of Endothelin-1 to Exercise Intolerance in Heart FailureCompletedEarly Phase 1VA Office of Research and DevelopmentNCT02124824Written as BQ-123
- The Role of Endothelin in the Supine Hypertension of Autonomic FailureWithdrawnPhase 1Vanderbilt UniversityNCT01119417Written as BQ123
- Insulin Stimulated Vasodilation in Patients With Type 2 DiabetesStatus unknownNot applicableUniversity of Southern DenmarkNCT04907838Written as BQ123
- The Role of Endothelin in Pulmonary HypertensionCompletedPhase 2Brigham and Women's HospitalNCT00759408Written as BQ-123
- The Contribution of Endothelin to Vasomotor Function in Diseased Coronary ArteriesCompletedNot applicableBrigham and Women's HospitalNCT00115583Written as Drug Infusion (BQ-123)
- Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMICompletedPhase 2Mayo ClinicNCT00586820Written as BQ-123
- Endothelin Receptor Blockade in Acute ST-elevation Myocardial InfarctionCompletedPhase 2Medical University of ViennaNCT00502528Written as BQ-123
- Role of Endothelin-1 in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy HumansCompletedNot applicableMedical University of ViennaNCT00915070Written as BQ-123
- Short-term Endothelin A Receptor Blockade in Patients With On-pump CABGStatus unknownPhase 2Medical University of ViennaNCT01658410Written as BQ-123
- Endothelin Receptor Antagonism in Proteinuric NephropathyCompletedPhase 1University of EdinburghNCT00722215Written as BQ-123 (selective endothelin A receptor antagonist)
- Endothelin-Receptor Blockade in Coronary Heart DiseaseCompletedPhase 1Medical University of ViennaNCT00427232Written as BQ-123 and BQ-788
Codes
What other systems call cyclo(Trp-Asp-Pro-Val-Leu) · ClinicalTrials.gg INT003601
- MeSH (NLM) C072247cyclo(Trp-Asp-Pro-Val-Leu)Confirmed ClinicalTrials.gov, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | Confirmed ClinicalTrials.gov, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.